Susan Blum
Directeur Financier/CFO chez MELINTA THERAPEUTICS, INC.
Provenance du réseau au premier degré de Susan Blum
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Private Company | Pharmaceuticals: Major | 32 | |
10
| Public Company | Biotechnology | 10 |
| Subsidiary | Internet Software/Services | 6 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Susan Blum via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Chairman General Counsel | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| Washington University in St. Louis | College/University | Doctorate Degree Masters Business Admin | |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Pharmaceuticals: Generic | Corporate Officer/Principal Human Resources Officer | |
Warburg Pincus LLC
 Warburg Pincus LLC Investment ManagersFinance Warburg Pincus LLC (Warburg Pincus) is a private equity subsidiary of Warburg Pincus & Company US LLC founded in 1966. The firm is headquartered in New York. | Investment Managers | Investment Committee Member Private Equity Investor | |
| Rochester Christian University | College/University | Masters Business Admin Graduate Degree | |
| ENDOLOGIX, INC. | Medical Specialties | Director/Board Member Director/Board Member | |
Allos Therapeutics, Inc.
 Allos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Allos Therapeutics, Inc. is a biopharmaceutical company committed to the development and commercialization of innovative anti-cancer therapeutics. It focuses on the development and commercialization FOLOTYN a pralatrexate injection. FOLOTYN is a folate analogue metabolic inhibitor designed to accumulate preferentially in cancer cells. It targets the inhibition of dihydrofolate reductase, or DHFR, an enzyme critical in the folate pathway, thereby interfering with DNA and RNA synthesis and triggering cancer cell death. Allos Therapeutics is also developing FOLOTYN in other hematologic malignancies and solid tumors. The company was founded on September 1, 1992 and is headquartered in Westminster, CO. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| MOMENTA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Cempra Pharmaceuticals, Inc.
 Cempra Pharmaceuticals, Inc. BiotechnologyHealth Technology Cempra Pharmaceuticals, Inc. develops medicines for treating drug-resistant bacterial infections. The firm's antibacterial products, both in clinical trials, address the urgent and increasing need for new treatments targeting drug-resistant bacterial infections in both the hospital and the community. The company was founded by Prabhavathi B. Fernandes IN 2006 and is headquartered in Chapel Hill, NC. | Biotechnology | Director/Board Member Director/Board Member Chief Executive Officer | |
Arisaph Pharmaceuticals, Inc.
 Arisaph Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Arisaph Pharmaceuticals, Inc. provides drug discovery services. It has various drug discovery programs to develop therapies for diabetes, cancer, and cardiovascular disease. The company was founded by Michael Jaharis, Christopher P. Kiritsy, and William Bachovchin in 1999 and is headquartered in Boston, MA | Pharmaceuticals: Major | Chairman Director/Board Member | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal Director/Board Member Director/Board Member | |
Edgemont Pharmaceuticals LLC
 Edgemont Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Edgemont Pharmaceuticals LLC develops and provides products for psychiatric disorders. The company was founded by Douglas A. Saltel in 2008 and is headquartered in Austin, TX. | Pharmaceuticals: Major | Director/Board Member Chairman | |
Chondrial Therapeutics, Inc.
 Chondrial Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Chondrial Therapeutics, Inc. operates as a biotechnology company which focuses on the treatment of rare mitochondrial diseases. Its compound is CTI-1601, which the company is developing as a potential treatment for Friedreich’s Ataxia. The company was founded by Steven R. Plump and Mark R. Payne and is headquartered in Bala Cynwyd, PA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
VirMedica, Inc.
 VirMedica, Inc. Packaged SoftwareTechnology Services VirMedica, Inc. provides technology solutions which designed to optimize the commercialization of specialty pharmaceutical products. It is an innovative holding company bringing together complimentary businesses for the specific purpose of redefining the market access landscape for specialty products. The company’s technology solution offers an end-to-end transformational platform to optimize specialty product commercialization and management. The company was founded by Mark K. Barnes in 2013 and is headquartered in Boston, MA. | Packaged Software | Chairman Director/Board Member | |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Doctorate Degree Undergraduate Degree | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Corporate Officer/Principal | |
Ortho-McNeil Pharmaceutical LLC
 Ortho-McNeil Pharmaceutical LLC Pharmaceuticals: MajorHealth Technology Ortho-McNeil Pharmaceutical LLC manufactures pharmaceutical products. Its products include ditropan, elmiron, modicon, otho cept and ortho novum etc. The company was founded in 1993 and is headquartered in Raritan, NJ. | Pharmaceuticals: Major | Private Equity Investor General Counsel | |
Mayer Brown LLP
 Mayer Brown LLP Miscellaneous Commercial ServicesCommercial Services Mayer Brown LLP provides legal services in areas of banking & finance, corporate & securities, litigation & dispute resolution antitrust & competition, US supreme court & appellate matters, employment & benefits, environmental, financial services regulatory & enforcement, government & global trade, intellectual property, real estate, tax, restructuring, bankruptcy & insolvency and wealth management. The company was founded in 1881 and is headquartered in Chicago, IL. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Talon Therapeutics, Inc.
 Talon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Talon Therapeutics, Inc. is a biopharmaceutical company, which is engaged in the developing and commercializing new and differentiated cancer therapies. The firm is developing the Marqibo for the treatment of acute lymphoblastic leukemia and other blood cancers including lymphoma. Its Menadione topical lotion is a compound which is developed for the prevention and treatment of skin toxicity associated with epidermal growth factor receptor inhibitors. The company was founded by Mark J. Ahn in 2002 and is headquartered in San Mateo, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Illinois State University | College/University | Undergraduate Degree | |
Warburg Pincus & Company US LLC
 Warburg Pincus & Company US LLC Investment ManagersFinance Warburg Pincus & Company US LLC engages in the provision of investment services. The company is headquartered in New York, NY. | Investment Managers | Corporate Officer/Principal Corporate Officer/Principal | |
| New York University | College/University | Masters Business Admin Masters Business Admin Undergraduate Degree | |
| Seton Hall University | College/University | Graduate Degree Undergraduate Degree | |
Tel-Aviv University
 Tel-Aviv University Other Consumer ServicesConsumer Services Tel-Aviv University operates as a university in Israel. Its faculties include arts, engineering, science, humanities, law, life science, management, medicine, and social science. The company was founded in 1956 and is headquartered in Ramat Aviv, Israel. | College/University | Graduate Degree Graduate Degree Graduate Degree | |
| The Hebrew University of Jerusalem | College/University | Undergraduate Degree Graduate Degree | |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | General Counsel Corporate Officer/Principal Director/Board Member Corporate Officer/Principal | |
Novo Nordisk, Inc.
 Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | Biotechnology | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Oikos Holdings LLC
 Oikos Holdings LLC Investment ManagersFinance Oikos Holdings LLC is a financial advisory services holding private company. The company is based in New York, NY and has subsidiaries in the United States. The company was founded by Kevin Thomas Ferro. | Investment Managers | Chief Executive Officer Chief Executive Officer Director/Board Member | |
Pearl Therapeutics, Inc.
 Pearl Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Pearl Therapeutics, Inc. develops therapies for the treatment of chronic respiratory diseases. It offers respiratory product development, high quality therapies for COPD, Asthma and treatment and prevention of chronic respiratory diseases and asthma. The company was founded in 2006 by Sarvajna Dwivedi and is headquartered in Redwood City, CA. | Pharmaceuticals: Major | Chairman Director/Board Member Corporate Officer/Principal | |
G&W Laboratories, Inc.
 G&W Laboratories, Inc. Pharmaceuticals: MajorHealth Technology G&W Laboratories, Inc. engages in the manufacturing and marketing pharmaceutical products. It offers generics and Rx products. The company was founded by Carl Greenblatt in 1919 and is headquartered in South Plainfield, NJ. | Pharmaceuticals: Major | Director of Finance/CFO President | |
| Harvard Medical School | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
| ALLERGAN PLC | Pharmaceuticals: Major | Investor Relations Contact Human Resources Officer | |
ImmusanT, Inc.
 ImmusanT, Inc. Medical SpecialtiesHealth Technology ImmusanT, Inc. develops a new class of therapeutic vaccines to change the lives of people living with autoimmune diseases. Its Epitope-Specific Immuno-Therapy platform provides a precision medicine approach to restoring immune tolerance across a range of diseases, including celiac disease and type 1 diabetes. The firm’s product Nexvax2, protects celiac disease patients against the debilitating effects of gluten. The company was by Leslie J. Williams and Robert P. Anderson founded in December 2010 and is headquartered in Cambridge, MA. | Medical Specialties | Chairman Director/Board Member Director/Board Member | |
Perspectum Ltd.
 Perspectum Ltd. Medical/Nursing ServicesHealth Services Perspectum Ltd. provides technology solutions for diagnosing and staging liver disease. The company was founded by Rajarshi Banerjee, Stefan Karl Neubauer, Matthew David Robson, Alastair Cavanagh, James Hugh Charteris Mallinson and John Michael Brady on September 18, 2012 and is headquartered in Oxford, the United Kindgom. | Medical/Nursing Services | Director of Finance/CFO Director/Board Member | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Corporate Officer/Principal | |
Healthquest Capital Management Co LLC
 Healthquest Capital Management Co LLC Investment ManagersFinance HealthQuest Capital Management Co LLC (HealthQuest Capital ) is a private equity firm founded in 2013 by Garheng Kong. The firm is headquartered in Redwood City, California. | Investment Managers | Private Equity Investor Founder | |
Deerfield Management Co. LP (Private Equity)
 Deerfield Management Co. LP (Private Equity) Investment ManagersFinance Deerfield Management Co. LP (Private Equity) (Deerfield) is a private equity subsidiary of Deerfield Management Co. LP founded in 1994. The firm is headquartered in the New York. | Investment Managers | Private Equity Investor Private Equity Investor Private Equity Investor | |
BiomX Ltd.
 BiomX Ltd. Pharmaceuticals: MajorHealth Technology BiomX Ltd. engages in the development of customized phage therapies designed to target and destroy harmful bacteria in chronic diseases such as inflammatory bowel disease and colorectalcancer, as well as bacteria that affect the appearance of the skin. The company was founded by Eran Elinav, Timothy K. Lu, and Rotem Sorek on March 3, 2015 and is headquartered in Ness Ziona, Israel. | Pharmaceuticals: Major | Chairman Corporate Officer/Principal Chief Executive Officer Corporate Officer/Principal | |
Chondrial Therapeutics Holdings LLC
 Chondrial Therapeutics Holdings LLC Miscellaneous Commercial ServicesCommercial Services Chondrial Therapeutics Holdings LLC engages in operation of a biotechnology firm. The company was founded in 2016 and is headquartered in Bala Cynwyd, PA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| XERIS BIOPHARMA HOLDINGS, INC. | Biotechnology | Director/Board Member Director/Board Member |
Statistiques
Internationale
| Etats-Unis | 43 |
| Israël | 5 |
| Hong Kong | 2 |
| Irlande | 2 |
| Royaume-Uni | 2 |
Sectorielle
| Health Technology | 29 |
| Consumer Services | 12 |
| Finance | 6 |
| Commercial Services | 4 |
| Technology Services | 2 |
Opérationnelle
| Director/Board Member | 239 |
| Corporate Officer/Principal | 99 |
| Independent Dir/Board Member | 66 |
| Chairman | 51 |
| Undergraduate Degree | 40 |
Relations les plus connectées
| Insiders | |
|---|---|
| Garheng Kong | 61 |
| Jonathan Leff | 45 |
| John Johnson | 40 |
| David Gill | 32 |
| Russell Greig | 31 |
| Aron Schwartz | 27 |
| Thomas Paul Koestler | 26 |
| Cecilia Gonzalo | 20 |
| Bruce Downey | 18 |
| Daniel Wechsler | 16 |
| Kevin Thomas Ferro | 15 |
| Jay Galeota | 15 |
| Edward Williams | 13 |
| Sumner Esten Anderson | 12 |
| Alan Moses | 11 |
- Bourse
- Insiders
- Susan Blum
- Connexions Sociétés
